ALSUntangled #66: antimycobacterial antibiotics.

Ellen S. Pierce, Paul Barkhaus, Morgan Beauchamp, Mark Bromberg, Gregory T. Carter, Jill Goslinga, David Greeley, Sky Kihuwa-Mani, Gleb Levitsky, Isaac Lund, Christopher McDermott, Gary Pattee, Kaitlyn Pierce, Meraida Polak, Dylan Ratner, Paul Wicks, Richard Bedlack

Research output: Contribution to journalReview articlepeer-review

Abstract

Several infections have been associated with motor neuron diseases resembling ALS, including species of viruses, bacteria, and parasites. Mycobacterium avium subspecies paratuberculosis (MAP), most known for its probable etiologic association with Crohn’s disease, has been suggested as another possible infectious cause of motor neuron disease. Two published case reports describe the successful treatment of ALS-like symptoms with antimycobacterial antibiotics. Both cases had atypical features. Based on these, we believe it would be reasonable to begin performing chest imaging in PALS who have features of their history or exam that are atypical for ALS such as pain, fevers, or eye movement abnormalities. If the chest imaging is abnormal, more specific testing for mycobacteria may be indicated. Until there is more clear evidence of an association between mycobacteria and ALS, we cannot endorse the widespread use of potentially toxic antimycobacterial antibiotics for PALS.

Original languageEnglish
Pages (from-to)539-543
Number of pages5
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume24
Issue number5-6
DOIs
StatePublished - 2023

Keywords

  • Amyotrophic lateral sclerosis
  • antimycobacterial antibiotic therapy
  • infectious ALS
  • motor neurone disease
  • paratuberculosis

Fingerprint

Dive into the research topics of 'ALSUntangled #66: antimycobacterial antibiotics.'. Together they form a unique fingerprint.

Cite this